Understanding the experiences of patients with chronic cancer treatments
Official title: LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
Run by University of Alberta · NCT05645510 · Data updated 2026-11-12
This study is trying to understand how people with advanced chronic cancer feel about their targeted treatments by having them share their experiences through interviews and creative expressions like art and music.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 75 (estimated) |
| Sponsor | University of Alberta Academic / other |
| Locations | 1 site (Edmonton, Alberta) |
| Status | Recruiting |
| Started | November 24, 2022 |
| Main results expected | June 9, 2026 |
| Study ends | June 9, 2026 |
| Registry record updated | May 11, 2026 |
| Trial ID | NCT05645510 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals currently receiving chronic targeted anti-cancer agents for conditions like breast cancer, melanoma, or multiple myeloma.
✕Probably not a fit
Patients who are not currently undergoing targeted anti-cancer treatments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on individuals with advanced chronic cancers who are receiving targeted anti-cancer treatments. Participants will engage in interviews to share their experiences with these treatments and reflect on how they impact their daily lives. Over a three-month period, they will create metaphors that express their experiences, using various forms of expression such as visual art, music, or verbal narratives. The goal is to gather insights that can help improve support for patients undergoing these treatments.
Why it matters
Potential benefit: If successful, this study could enhance the support and resources available to patients undergoing targeted cancer treatments.
How similar studies have gone: While this approach is relatively novel in its focus on personal expression, similar studies have shown success in understanding patient experiences with chronic illnesses.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: taking chronic targeted anti-cancer agents - Exclusion Criteria: \-
Where it's running
-
Edith Pituskin
Edmonton, Alberta, Canada Recruiting
Study contacts
- Study coordinator: Edith Pituskin, PhD
- Email: pituskin@ualberta.ca
- Phone: 7804328221
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
IDOV-Immune for advanced solid tumors
This trial will try a single IV infusion of an engineered oncolytic vaccinia virus called IDOV-Immune in adults with advanced solid tumors that no longer respond to standard treatments.
-
Using Riluzole to Help Breast Cancer Survivors with Cognitive Issues
This study is testing if the medication riluzole can help breast cancer survivors who are having trouble with thinking and memory feel better.
-
Validation of a blood test for early cancer detection and monitoring
This study is testing a blood test to see if it can help find different types of cancer early and monitor patients after treatment.
-
Evaluating progastrin levels in cancer patients
This study is testing if measuring progastrin levels in the blood can help predict how cancer will progress and respond to treatment in patients with different types of cancer.
-
A resource for collecting cancer data and biospecimens
This study is creating a resource to collect health information and samples from cancer patients and healthy individuals to help improve cancer prevention and treatment strategies.
-
Collecting blood and leftover tumor tissue to test molecular residual disease (MRD) detection
This project will test whether blood and leftover tumor tissue from adults with certain solid tumors can be used with Natera's MRD blood tests to find tiny amounts of cancer (ctDNA) after treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.